Literature DB >> 1008914

ABO blood group and cardiovacular disease: the Framingham study.

R J Garrison, R J Havlik, R B Harris, M Feinleib, W B Kannel, S J Padgett.   

Abstract

Following determination of ABO blood type at the sixth biennial examination, the Framingham Heart Study cohort was followed for the occurrence of cardiovascular events for a period of 10 years. A significant association was found between blood type and intermittent claudication, with blood group O showing the lowest rates. Slight but non-significant excesses for certain other CHD events were also found in non-O individuals. Serum cholesterol showed marginally significant but consistent elevations in non-O subjects but the increased risk in non-O individuals was found to occur independently of the known intermittent claudication risk factors. Since the observed relationship between blood type and intermittent claudication occurs independently of the usual atherosclerotic risk factors, blood type, possibily through an effect on clotting, should be considered in the pathogenesis of intermittent claudication.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008914     DOI: 10.1016/0021-9150(76)90036-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  30 in total

1.  ABO blood group is associated with peripheral arterial disease in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Mindy M Pike; Nicholas B Larson; Christina L Wassel; Kevin P Cohoon; Michael Y Tsai; James S Pankow; Naomi Q Hanson; Paul A Decker; Cecilia Berardi; Kristine S Alexander; Mary Cushman; Neil A Zakai; Suzette J Bielinski
Journal:  Thromb Res       Date:  2017-02-24       Impact factor: 3.944

2.  Blood groups, serum cholesterol, serum uric acid, blood pressure, and obesity in adolescents.

Authors:  R F Gillum
Journal:  J Natl Med Assoc       Date:  1991-08       Impact factor: 1.798

Review 3.  Blood group antigens: molecules seeking a function?

Authors:  P Greenwell
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

Review 4.  Genetic basis of atherosclerosis: insights from mice and humans.

Authors:  Ioannis M Stylianou; Robert C Bauer; Muredach P Reilly; Daniel J Rader
Journal:  Circ Res       Date:  2012-01-20       Impact factor: 17.367

Review 5.  Is ABO blood group truly a risk factor for thrombosis and adverse outcomes?

Authors:  Shan Zhou; Ian Welsby
Journal:  World J Cardiol       Date:  2014-09-26

6.  ABO blood group and risk of coronary heart disease in two prospective cohort studies.

Authors:  Meian He; Brian Wolpin; Kathy Rexrode; Joann E Manson; Eric Rimm; Frank B Hu; Lu Qi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-14       Impact factor: 8.311

7.  Targeted Sequencing Study to Uncover Shared Genetic Susceptibility Between Peripheral Artery Disease and Coronary Heart Disease-Brief Report.

Authors:  Maya S Safarova; Xiao Fan; Erin E Austin; Natalie van Zuydam; Jemma Hopewell; Daniel J Schaid; Iftikhar J Kullo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06       Impact factor: 8.311

8.  The association between blood group and the risk of vascular disease in Quebec blood donors.

Authors:  Claudia Blais; Marc Germain; Gilles Delage; Yves Grégoire
Journal:  Blood Transfus       Date:  2016-04-28       Impact factor: 3.443

9.  Polymorphisms of Lewis and Secretor genes are related to breast cancer and metastasis in axillary lymph nodes.

Authors:  Debora Barreto Teresa; Raquel Alves Santos; Catarina Satie Takahashi; Helio H Carrara; Haroldo W Moreira; Luis Carlos Mattos; Nicolino Lia-Neto; Leonardo A Cunha; Carmem Lucia Bassi; Edson Garcia Soares; Eduardo Antonio Donadi; Elaine Rodrigues Mello; Christiane Pienna Soares
Journal:  Tumour Biol       Date:  2010-06-01

10.  Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels.

Authors:  Maja Barbalic; Josée Dupuis; Abbas Dehghan; Joshua C Bis; Ron C Hoogeveen; Renate B Schnabel; Vijay Nambi; Monique Bretler; Nicholas L Smith; Annette Peters; Chen Lu; Russell P Tracy; Nena Aleksic; Jan Heeriga; John F Keaney; Kenneth Rice; Gregory Y H Lip; Ramachandran S Vasan; Nicole L Glazer; Martin G Larson; Andre G Uitterlinden; Jennifer Yamamoto; Peter Durda; Talin Haritunians; Bruce M Psaty; Eric Boerwinkle; Albert Hofman; Wolfgang Koenig; Nancy S Jenny; Jacqueline C Witteman; Christie Ballantyne; Emelia J Benjamin
Journal:  Hum Mol Genet       Date:  2010-02-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.